Gabor Kovacs
Overview
Explore the profile of Gabor Kovacs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
376
Citations
6481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Peterffy B, Krizsan S, Egyed B, Bedics G, Benard-Slagter A, Palit S, et al.
Mod Pathol
. 2025 Feb;
38(6):100741.
PMID: 40010436
Risk-adapted treatment protocols conferred remarkable improvement in the survival rates of pediatric acute lymphoblastic leukemia/lymphoma (ALL/LBL). Nevertheless, clinical management is still challenging in certain molecular subgroups and in the presence...
3.
Yogeswaran A, Funderich M, Olschewski H, Kovacs G, Kiely D, Lawrie A, et al.
ERJ Open Res
. 2025 Feb;
11(1).
PMID: 40008170
Introduction: The definition of pulmonary hypertension (PH) was recently changed and led to a new subset of PH patients with mildly impaired pulmonary haemodynamics, characterised by a mean pulmonary artery...
4.
Haller J, Faludi G, Kovacs G, Purebl G, Fuzesi Z, Freund T
Pharmaceuticals (Basel)
. 2025 Feb;
18(2).
PMID: 40006076
: extracts with unique alkamide profiles (EP107™) have been shown to affect upper respiratory tract infections and reduce anxiety in both animals and humans. However, a recent study found that...
5.
Egyed B, Arvai K, Zajta E, Hegyi L, Andrassy B, Kovacs A, et al.
Orv Hetil
. 2025 Jan;
166(1):3-19.
PMID: 39786397
No abstract available.
6.
Zeder K, Sassmann T, Foris V, Douschan P, Olschewski H, Kovacs G
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
17:100519.
PMID: 39711774
Severe pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD) is currently defined by an elevated mean pulmonary arterial pressure and strongly elevated pulmonary vascular resistance >5 wood units. Clinically,...
7.
Sterniste G, Hackner K, Moazedi-Furst F, Grasl M, Idzko M, Shao G, et al.
Wien Klin Wochenschr
. 2024 Dec;
137(1-2):62-63.
PMID: 39680105
No abstract available.
8.
Botos B, Erhardt J, Jenei S, Li K, Kovacs D, Egyed B, et al.
Magy Onkol
. 2024 Dec;
68(4):313.
PMID: 39657042
RASopathies are congenital diseases that manifest in childhood with symptoms and potential complications, typically associated with an elevated tumour predisposition risk. The heterogeneous symptoms involve mostly central nervous, cardiovascular, musculoskeletal...
9.
Simonyi G, Burnier M, Narkiewicz K, Rokszin G, Abonyi-Toth Z, Kovacs G, et al.
J Hypertens
. 2024 Dec;
43(3):405-412.
PMID: 39641301
Objectives: Hypertension guidelines recommend the use of single-pill combinations (SPCs) of antihypertensive drugs to improve treatment persistence and blood pressure control. This study aimed to investigate the long-term effects of...
10.
Zeder K, Avian A, Olschewski H, Kovacs G
Eur Respir J
. 2024 Nov;
64(5).
PMID: 39609039
No abstract available.